NM_001367561.1:c.145G>A
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP3_Strong
The NM_001367561.1(DOCK7):c.145G>A(p.Val49Met) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000803 in 1,606,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V49L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001367561.1 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 23Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DOCK7 | NM_001367561.1 | c.145G>A | p.Val49Met | missense_variant, splice_region_variant | Exon 3 of 50 | ENST00000635253.2 | NP_001354490.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152030Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000405 AC: 10AN: 246620 AF XY: 0.0000375 show subpopulations
GnomAD4 exome AF: 0.0000791 AC: 115AN: 1454656Hom.: 0 Cov.: 31 AF XY: 0.0000774 AC XY: 56AN XY: 723276 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74378 show subpopulations
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 23 Uncertain:2
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 49 of the DOCK7 protein (p.Val49Met). This variant is present in population databases (rs374725632, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with DOCK7-related conditions. ClinVar contains an entry for this variant (Variation ID: 475127). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Inborn genetic diseases Uncertain:1
The c.145G>A (p.V49M) alteration is located in exon 3 (coding exon 3) of the DOCK7 gene. This alteration results from a G to A substitution at nucleotide position 145, causing the valine (V) at amino acid position 49 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at